Recent FTC orders require Caremark Rx and Express Scripts to stop favoring high-list-price versions of drugs over their standard formularies; today’s blog looks at the settlement terms most relevant to plan sponsors and members.
Legislative and regulatory developments on pharmacy benefit manager (PBM) oversight continue to be released—today’s blog covers how rebates will be impacted.
